Hershey, PA, United States of America

Shuwen Wang

This inventor holds 9 USPTO granted patents and 1 published patent application. Top assignee: Elan Pharmaceuticals, Inc.. Active years: 2003-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuwen Wang. Retrieved from https://idiyas.com/inventor/shuwen-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 66.7

Average Co-Inventor Count = 11.0

ph-index = 7

Forward Citations = 77(Granted Patents)


Location History:

  • Hersey, PA (US) (2003 - 2006)
  • Hershey, PA (US) (2007 - 2008)

Company Filing History:


Years Active: 2003-2008

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Journey of Shuwen Wang

Introduction: Shuwen Wang, a pioneering inventor based in Hershey, PA, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Shuwen Wang holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Shuwen Wang has worked with leading tech companies, research institutions, and universities, consistently pushing the boundaries of innovation.

Collaborations: Throughout her career, Shuwen Wang has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge exchange.

Conclusion: Shuwen Wang's relentless pursuit of innovation and her passion for creating a positive impact on society solidify her position as a trailblazing inventor in the modern technological landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…